GGrantIndex
← Search

Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein

$339,597R44FY2019AINIH

Meissa Vaccines, Inc., South San Francisco CA

Investigators

View original record on NIH RePORTER →